|Other Names||Cyclin-dependent kinase inhibitor 3, CDK2-associated dual-specificity phosphatase, Cyclin-dependent kinase interactor 1, Cyclin-dependent kinase-interacting protein 2, Kinase-associated phosphatase, CDKN3, CDI1, CIP2, KAP|
|Target/Specificity||The synthetic peptide sequence is selected from aa 54-68 of HUMAN CDKN3|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Synonyms||CDI1, CIP2, KAP|
|Function||May play a role in cell cycle regulation. Dual specificity phosphatase active toward substrates containing either phosphotyrosine or phosphoserine residues. Dephosphorylates CDK2 at 'Thr-160' in a cyclin-dependent manner.|
|Cellular Location||Cytoplasm, perinuclear region|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The protein encoded by this gene belongs to the dual specificity protein phosphatase family. It was identified as a cyclin-dependent kinase inhibitor, and has been shown to interact with, and dephosphorylate CDK2 kinase, thus prevent the activation of CDK2 kinase. This gene was reported to be deleted, mutated, or overexpressed in several kinds of cancers. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Shimada, M., et al. Hum. Genet. 128(4):433-441(2010)
Jiang, R., et al. Int. J. Cancer 126(5):1263-1274(2010)
Okamoto, K., et al. Biochem. Biophys. Res. Commun. 351(1):216-222(2006)
Hsieh, M.J., et al. Biochem. Biophys. Res. Commun. 349(2):573-581(2006)
Chinami, M., et al. J. Biol. Chem. 280(17):17235-17242(2005)
If you have any additional inquiries please email technical services at email@example.com.